Allogeneic ADSCs induce CD8 T cell-mediated cytotoxicity and faster cell death after exposure to xenogeneic serum or proinflammatory cytokines

被引:12
作者
Chang, Sung-Ho [1 ,2 ,3 ,4 ]
Park, Chung-Gyu [1 ,2 ,3 ,5 ,6 ]
机构
[1] Seoul Natl Univ, Coll Med, Med Res Ctr, Inst Endem Dis, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Xenotransplantat Res Ctr, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biochem & Mol Biol, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
关键词
MESENCHYMAL STEM-CELLS; STROMAL CELLS; THERAPY;
D O I
10.1038/s12276-019-0231-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study examined the induction of recipient T-cell cytotoxicity after exposure to allogeneic adipose-derived mesenchymal stem cells (ADSCs). ADSCs pre-exposed to xenogeneic serum significantly induced cytotoxicity through CD8 T-cell granzyme B secretion after allogeneic antigen stimulation, and this effect was increased with prolonged reaction time. ADSCs pretreated with proinflammatory cytokines also induced cytotoxicity through granzyme B secretion and significantly increased human leukocyte antigen (HLA)-ABC expression. T-cell cytotoxicity towards ADSCs grown in xeno-free medium (XF-ADSCs) was lower than that towards ADSCs exposed to xenogeneic serum or proinflammatory cytokines, but XF-ADSCs still induced cytotoxicity. We further investigated the causes of T-cell cytotoxicity towards XF-ADSCs. XF-ADSC death was effectively inhibited by HLA-blocking antibodies, suggesting that ADSC HLAs are a major cause of alloreactive T-cell generation. These results indicated that culturing of allogeneic ADSCs with recipient serum may alleviate alloreactive CD8 T-cell cytotoxicity. Ultimately, development of therapeutic agents using autologous ADSCs would be a suitable way to avoid immunogenicity and CD8 T cell-mediated cytotoxicity, but more attention should be paid to the potential immunogenicity of allogeneic ADSCs, which could perhaps be mitigated through the use of immunosuppressants.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 40 条
[1]  
Abbas A.K., 2018, Cellular and molecular immunology
[2]   Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy? [J].
Alagesan, Senthilkumar ;
Griffin, Matthew D. .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2014, 19 (01) :65-72
[3]   Vaccine against autoimmune disease: antigen-specific immunotherapy [J].
Anderson, Robert P. ;
Jabri, Bana .
CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (03) :410-417
[4]   Mesenchymal stem cells: immune evasive, not immune privileged [J].
Ankrum, James A. ;
Ong, Joon Faii ;
Karp, Jeffrey M. .
NATURE BIOTECHNOLOGY, 2014, 32 (03) :252-260
[5]   Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum [J].
Ben Azouna, Nesrine ;
Jenhani, Faouzi ;
Regaya, Zohra ;
Berraeis, Lamia ;
Ben Othman, Tarek ;
Ducrocq, Elfi ;
Domenech, Jorge .
STEM CELL RESEARCH & THERAPY, 2012, 3
[6]   Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases [J].
Ben-Ami, Eyal ;
Berrih-Aknin, Sonia ;
Miller, Ariel .
AUTOIMMUNITY REVIEWS, 2011, 10 (07) :410-415
[7]   Immunologic and Inflammatory Reactions to Exogenous Stem Cells Implications for Experimental Studies and Clinical Trials for Myocardial Repair [J].
Buja, L. Maximilian ;
Vela, Deborah .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (21) :1693-1700
[8]   A look at the interface between mesenchymal stromal cells and the immune system [J].
Ceredig, Rhodri .
IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (01) :3-4
[9]   Suppression of the immune system as a critical step for bone formation from allogeneic osteoprogenitors implanted in rats [J].
Chatterjea, Anindita ;
LaPointe, Vanessa L. S. ;
Alblas, Jacqueline ;
Chatterjea, Supriyo ;
van Blitterswijk, Clemens A. ;
de Boer, Jan .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (01) :134-142
[10]   Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice [J].
Eliopoulos, N ;
Stagg, J ;
Lejeune, L ;
Pommey, S ;
Galipeau, J .
BLOOD, 2005, 106 (13) :4057-4065